FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to cardiology. A risk index of developing atrial fibrillation (RIDAF) is determined by an original formula before and after the antiarrhythmic therapy (AAT) used for at least 7 half-lives of the preparation. If observing an increase in the RIDAF produced after the AAT as compared to the pre-RIDAF performed earlier, pharmacological AAT is predicted as the primary prevention of AF in the patients with HE as effective.
EFFECT: method enables predicting the effectiveness of pharmacological AAT as primary prevention of atrial fibrillation in patients with atrial ectrophystolia.
1 cl, 4 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL EXTRASYSTOLE | 2021 |
|
RU2763978C1 |
| METHOD FOR PREDICTION OF DURATION OF PRESERVATION OF POSITIVE EFFECT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH EXTRASYSTOLIA | 2020 |
|
RU2749851C1 |
| METHOD FOR PREDICTING EFFECTIVENESS OF MODULATED KINESITHERAPY AS A PRIMARY PREVENTION OF ATRIAL FIBRILLATION IN PATIENTS WITH ATRIAL EXTRASYSTOLE | 2017 |
|
RU2667827C1 |
| METHOD FOR DETERMINING RISK OF ATRIAL FIBRILLATION IN PATIENTS WITH PREMATURE ATRIAL CONTRACTION | 2014 |
|
RU2556602C1 |
| METHOD FOR SELECTION OF MOST EFFECTIVE ANTIARRHYTHMIC DRUG FOR PATIENTS WITH EXTRASISTOLY | 2017 |
|
RU2641164C1 |
| METHOD OF DETERMINING RISK OF ATRIUM FIBRILLATION DEVELOPMENT | 2012 |
|
RU2497446C1 |
| METHOD FOR SELECTING AN EFFECTIVE ANTIARRHYTHMIC AGENT FOR PATIENTS WITH PREMATURE HEART BEATS | 2019 |
|
RU2707261C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF ATRIAL PAROXYSMS OF FLUTTER AND FIBRILLATION IN PATIENTS WITH SUPRAGASTRIC EXTRASYSTOLIA | 2006 |
|
RU2312592C1 |
| METHOD FOR DETERMINING THE RISK DEVELOPMENT OF ATRIAL FIBRILLATION IN PATIENTS WITH PREMATURE ATRIAL CONTRACTION | 2017 |
|
RU2657189C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF PAROXYSMS OF ATRIAL FLUTTER AND FIBRILLATION IN PATIENTS AT SUPRAVENTRICULAR EXTRASYSTOLIA | 2005 |
|
RU2294137C2 |
